000 01732nam  2200373zi 4500
0019.897461
003CaOODSP
00520221107174609
006m     o  d f      
007cr cn|||||||||
008210312e202102  abca    ob   f000 0 eng d
020 |a9780660378824
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aMR4-95/2021E-PDF
24500|aMental health and substance use impacts of COVID-19 : |blay summary of knowledge synthesis projects.
264 1|aCalgary, AB : |bCIHR, Institute of Neurosciences, Mental Health and Addiction = IRSC, Institut des neurosciences, santé mentale et des toxicomanies, |cFebruary 2021.
264 4|c©2021
300 |a1 online resource (22 pages) : |bcolour illustrations
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aIssued also in French under title: Les répercussions de la COVID-19 sur la santé mentale et la toxicomanie : résumé non scientifique de projets de synthèse des connaissances.
500 |aIssued also in HTML format.
504 |aIncludes bibliographical references.
650 0|aMental health|zCanada.
650 0|aSubstance abuse|zCanada.
650 0|aCOVID-19 Pandemic, 2020-|zCanada|xPsychological aspects.
7102 |aInstitute of Neurosciences, Mental Health and Addiction (Canada), |eissuing body.
77508|tLes répercussions de la COVID-19 sur la santé mentale et la toxicomanie : |w(CaOODSP)9.897462
85640|qPDF|s977 KB|uhttps://publications.gc.ca/collections/collection_2021/irsc-cihr/MR4-95-2021-eng.pdf
8564 |qHTML|sN/A|uhttps://cihr-irsc.gc.ca/e/52373.html